Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma
Testing for NRAS is now integral part in the assessment of metastatic melanoma patients because there is evidence that NRAS -mutated patients may be sensitive to MEK inhibitors, and RAS mutation is a common mechanism of acquired resistance during treatment with BRAF inhibitors. This study evaluated...
Gespeichert in:
Veröffentlicht in: | Modern pathology 2015-04, Vol.28 (4), p.487-497 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!